Antonio Giordano to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Antonio Giordano has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
1.082
-
Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
Score: 0.537
-
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial. Int J Med Sci. 2021; 18(10):2245-2250.
Score: 0.147
-
Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis. Lancet Oncol. 2019 10; 20(10):1360-1369.
Score: 0.132
-
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience. J Cell Physiol. 2019 06; 234(6):7708-7717.
Score: 0.126
-
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting. J Cell Physiol. 2018 Mar; 233(3):2313-2323.
Score: 0.116
-
Circulating tumor cells in newly diagnosed inflammatory breast cancer. Breast Cancer Res. 2015 Jan 09; 17:2.
Score: 0.024